anticipation |
11-17-2011 04:24 PM |
Quote:
Originally Posted by Mrd00d
(Post 1121023)
They're still doing research, although some research has leaked that at least the U.S. is trying to cover up... that smoking pot reduces risks of cancer, etc., but in general, the scientific community is quite unsure about the effects/benefits exactly are.
It's been illegal for so long and nobody was allowed to really do research besides at the one research center (in the US) in like... the South, like Alabama where they made kind of mediocre weed for research so that the results came up with little to nothing good to say.
In this day and age, prohibition is slipping and more legitimate research is being done in Europe and the like, and some places in the US. The government doesn't want to research legitimately good marijuana...
|
Please, please stop spreading misinformation like this. The effects of cannabis on the human body have been well known by legislators for over 60 years because every US government-sponsored study has openly shown the benefits and medicinal capabilities of marijuana. The government chooses not to use this information, but each of these reports is accessible to the public and clearly state the efficacy of marijuana for a number of symptomatic and even cancerous ailments. Ever heard of Sativex? Marinol? Those are the names of THC and CBD based perscription drugs given to hundreds of thousands of people accross North America and Europe every year in a crude attempt at replicating marijuana's effects. Pharmaceutical lobbyists pay exorbitant amounts of money to cover up the fact that there hasn't been a single synthetic product made that can ever compare up to the real thing.
Here's a great little copy and paste for anyone who thinks I'm just blowing smoke...(get it?):
Cannabinoids have been found to have antioxidant properties, unrelated to NMDA receptor antagonism. This new found property makes cannabinoids useful in the treatment and prophylaxis of wide variety of oxidation associated diseases, such as ischemic, age-related, inflammatory and autoimmune diseases. The cannabinoids are found to have particular application as neuroprotectants, for example in limiting neurological damage following ischemic insults, such as stroke and trauma, or in the treatment of neurodegenerative diseases, such as Alzheimer's disease, Parkinson's disease and HIV dementia. Nonpsychoactive cannabinoids, such as cannabidoil, are particularly advantageous to use because they avoid toxicity that is encountered with psychoactive cannabinoids at high doses useful in the method of the present invention. A particular disclosed class of cannabinoids useful as neuroprotective antioxidants is formula (I) wherein the R group is independently selected from the group consisting of H, CH3, and COCH3.
This comes from U.S. Patent # 6630507, filed by US Department of Health and Human Services due to new findings by the National Institute of Mental Health and the National Institute of Neurological Disorders and Stroke.
|